SureTrader
Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

http://www.nasdaq.com/symbol/ino/after-hours

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Banks Member Profile
 
Followed By 56
Posts 11,035
Boards Moderated 0
Alias Born 05/02/05
160x600 placeholder
Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Mala... GlobeNewswire Inc. - 2/12/2018 8:00:00 AM
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences GlobeNewswire Inc. - 2/5/2018 8:45:55 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/25/2018 11:25:34 AM
Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1... GlobeNewswire Inc. - 1/22/2018 8:00:00 AM
Inovio’s Co-Founder along with its Lead Antigen Designer Named Among Top 20 Researchers With Most Granted U.S Patents for ... GlobeNewswire Inc. - 1/17/2018 8:00:00 AM
Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Eval... GlobeNewswire Inc. - 1/9/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2018 8:17:32 AM
Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squa... GlobeNewswire Inc. - 1/8/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/2/2018 4:07:26 PM
Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China GlobeNewswire Inc. - 1/2/2018 8:00:00 AM
Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development GlobeNewswire Inc. - 12/11/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/6/2017 2:08:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/6/2017 2:06:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2017 1:58:14 PM
Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors GlobeNewswire Inc. - 12/6/2017 8:00:00 AM
Inovio’s Further Analysis of VGX-3100 Phase 2b Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clini... GlobeNewswire Inc. - 11/29/2017 8:00:00 AM
Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor a... GlobeNewswire Inc. - 11/27/2017 8:00:00 AM
Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference GlobeNewswire Inc. - 11/10/2017 10:27:55 AM
Inovio Pharmaceuticals to Participate In Upcoming Investment Conferences GlobeNewswire Inc. - 11/9/2017 8:00:00 AM
Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results GlobeNewswire Inc. - 11/8/2017 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 3:58:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2017 6:07:10 AM
Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhi... GlobeNewswire Inc. - 11/1/2017 9:18:26 AM
Inovio Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 8, 2017 GlobeNewswire Inc. - 10/26/2017 8:00:00 AM
Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study... GlobeNewswire Inc. - 10/24/2017 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist